Financial Data and Key Metrics Changes - For Q4 2025, the company reported revenue of $170 million, a 19.6% increase year-over-year, exceeding the projected $157 million [9][33] - Full year revenue for 2025 was $839 million, reflecting a 14.6% growth compared to the previous year [10][35] - The net income for Q4 was $199 million, marking a 48% increase year-over-year, while the adjusted net income for the full year was $217 million, with a margin of 25.9% [12][39] Business Line Data and Key Metrics Changes - All four business segments, including Private Client Services, commercial, alternative investment funds, and Valuation, experienced double-digit growth [9] - Private Client Services accounted for 51.5% of total revenue for the year, with no significant change in revenue mix [36] Market Data and Key Metrics Changes - The number of client groups generating over $250,000 in revenue increased to 687 in 2025 from 629 in 2024, indicating healthy client growth [36] - The average rate per hour increased by approximately 11% year-over-year, demonstrating the firm's ability to raise prices [37] Company Strategy and Development Direction - The company aims to focus on productivity improvements, profitability management, and integration of acquired firms as part of its 2026 strategy [13][16] - The acquisition strategy involves selectively rolling up existing networks into the business, with a focus on groups that have established relationships with the company [18][20] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the business's performance, noting that recurring revenue growth in late 2025 was strong, with expectations for continued momentum into 2026 [52] - The company anticipates revenue for 2026 to be in the range of $955 million to $970 million, reflecting a growth rate of 14%-15% [43] Other Important Information - The company incurred a net loss of $195.9 million in Q4 due to one-off equity restructuring costs and IPO-related expenses [34] - Cash and equivalents on the balance sheet as of December 31, 2025, were $258.5 million, with no third-party debt, indicating strong liquidity [41] Q&A Session Summary Question: What is the outlook for revenue growth momentum into 2026? - Management indicated that the guidance provided is conservative, with expectations to elevate revenue objectives based on strong recurring revenue growth observed in late 2025 [52][53] Question: How is the company addressing pricing increases and client pushback? - Management acknowledged some pushback on pricing in competitive service areas but emphasized a focus on value-added services rather than commodity pricing [61] Question: What is the contribution of acquisitions to the revenue guidance? - Management stated that approximately $21 million of the projected $33 million in inorganic revenue is from recently signed deals, with expectations to outperform this number [75]

Financial Data and Key Metrics Changes - Oklo reported a loss from operations of $139.3 million for the full year 2025, primarily due to payroll, general business expenses, and professional fees related to capital market and asset deployment activities [34] - The operating loss included non-cash stock-based compensation expense of $41.8 million, influenced by an increase in the firm's share price during the year [34] - Cash used in operating activities was $82.2 million, which included approximately $13 million of prepaid capital project expenses [35] - The company adjusted its guidance for cash used in operating activities for 2026 to a range of $80 million to $100 million, reflecting an increase in headcount and project investments [36] Business Line Data and Key Metrics Changes - The company transitioned from product development to active project deployment across all business units, including power, fuel, and isotopes [4] - Significant progress was made in the power business unit with the Aurora powerhouse at Idaho National Laboratory and a prepayment agreement with Meta for a 1.2-gigawatt power campus in Ohio [4][18] - In the fuel business unit, A3F received DOE approval and was selected under the DOE Advanced Nuclear Fuel Line Pilot Program, with initial construction activities underway [24][25] - The isotopes business unit is advancing with the Groves radioisotope test reactor, which is progressing through the DOE authorization pathway [29] Market Data and Key Metrics Changes - The U.S. nuclear policy has shifted towards a more execution-oriented posture, providing a strong tailwind for the nuclear sector, which Oklo is positioned to capitalize on [6][7] - The demand for firm, reliable power is growing across various sectors, including data centers and industrial customers, which supports the company's power business strategy [8] Company Strategy and Development Direction - Oklo's strategy focuses on building a vertically integrated nuclear platform that includes power generation, fuel production, and isotope services [7][12] - The integration across the value chain aims to unlock multiple complementary value streams, enhancing the overall economics of the business [12][14] - The company is pursuing a differentiated strategy to accelerate nuclear deployment, addressing supply chain bottlenecks and enhancing fuel availability [24][36] Management's Comments on Operating Environment and Future Outlook - Management highlighted the importance of the regulatory environment and the support from federal mechanisms, which are expected to improve project funding pathways [6][16] - The company is optimistic about the future, with plans to expand investments across all business units and capitalize on favorable policy changes [36][37] Other Important Information - Oklo ended 2025 with cash and marketable securities of $1.4 billion and raised an additional $1.182 billion in early 2026, completing its $1.5 billion ATM program [37] - The company is focused on maintaining a disciplined approach to cash management and capital allocation while pursuing growth opportunities [35][36] Q&A Session Summary Question: Update on commercialization progress and customer pipeline - Management noted that Meta is an important anchor customer, and discussions are ongoing with other potential customers, including military and industrial clients [40][41] Question: Breakdown of CapEx guidance for 2026 - Management refrained from providing a detailed breakdown but indicated that significant spending will occur across all three business units, particularly in Idaho and Ohio [43][44] Question: Status of regulatory strategy and licensing timelines - Management explained the distinction between DOE authorization and NRC licensing, emphasizing the advantages of the DOE pathway for faster project execution [49][50][52]

Financial Data and Key Metrics Changes - Total revenue for 2025 was $357.5 million, up 0.4% from $356 million in 2024, and adjusted EBITDA was $42 million, up 2.6% from 2024, resulting in an adjusted EBITDA margin of 11.8% [9][10][15] - Core operating expenses for 2025 increased by 1% year-over-year, primarily due to higher employee incentive compensation and revenue share costs [11] Business Line Data and Key Metrics Changes - Content & Ad Measurement revenue was $304.3 million, up 1% from 2024, driven by growth in cross-platform and local TV offerings [9] - Cross-platform revenue reached $50.3 million, up 24.4% compared to the prior year, attributed to higher usage of Proximic and CCR products, along with the successful rollout of CCM [9][10] - Syndicated Audience revenue was $253.9 million, down 2.6% from 2024, due to declines in national TV and syndicated digital offerings [10] - Movies business generated $38.4 million in revenue, up 3.4% from the prior year [10] Market Data and Key Metrics Changes - The local TV business experienced double-digit growth, contributing significantly to overall performance [10][12] - Cross-platform offerings are expected to continue driving growth, with double-digit growth projected for 2026 [15] Company Strategy and Development Direction - The company aims to become the industry standard for modern measurement by integrating offerings across planning, activation, buying, and measurement [6][7] - Focus on AI measurement innovation to understand consumer behavior and purchase decisions influenced by AI tools [7][8] - The recapitalization transaction was a strategic move to simplify the capital structure and enhance financial flexibility [3][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth of cross-platform offerings and local TV adoption as key drivers for 2026 [15] - The company anticipates revenue in Q1 2026 to be roughly flat compared to Q1 2025, while continuing to invest in key business areas [16] Other Important Information - The company successfully eliminated $18 million in annual dividends and a $47 million special dividend obligation through recapitalization [3] - The board size was reduced to streamline costs and governance [3] Q&A Session Questions and Answers Question: Financial flexibility with structural changes - Management highlighted the elimination of $18 million in dividends and reduced board costs as key elements that enhance financial flexibility for future investments [19] Question: Utilization of existing partners and adding new partners - Management noted increased usage of cross-platform products and ongoing expansion of partnerships, with positive early adoption of CCM [20][21] Question: Local market evolution - Management indicated strong performance in local market transactions and anticipated continued success as audience-based buying evolves [22][23]

Financial Data and Key Metrics Changes - For Q4 2025, the company reported revenue of $170 million, a 19.6% increase year-over-year, exceeding the projected $157 million [9][32] - Full-year revenue for 2025 was $839 million, reflecting a 14.6% growth compared to the previous year [10][34] - The net income for Q4 2025 was $199 million, marking a 48% increase from the previous year, while the adjusted net income for the full year was $217 million, with a margin of 25.9% [12][38] Business Line Data and Key Metrics Changes - All four business segments, including Private Client Services, commercial, alternative investment funds, and valuation, experienced double-digit growth [9] - Private Client Services accounted for 51.5% of total revenue for the year, with a healthy increase in the number of client groups generating over $250,000 in revenue [35] Market Data and Key Metrics Changes - The company expanded its client relationships, increasing the number of active client groups by 5.6% and client engagements by 10.6% year-over-year [36] - The average rate per hour increased by approximately 11% year-over-year, indicating the firm's ability to raise prices [36] Company Strategy and Development Direction - The company aims to focus on productivity, profitability, integration, and acquisitions as part of its 2026 strategy [13][16] - There is a strong emphasis on technology as a competitive advantage, with plans to implement AI and other technological solutions thoughtfully [22][23] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the business's performance, noting that recurring revenue growth in late 2025 was strong, with expectations to elevate revenue objectives in future calls [52][57] - The company anticipates a net loss in 2026 primarily due to non-cash equity-based compensation expenses, but expects continued revenue growth in core practices [42][43] Other Important Information - The company has a strong balance sheet with $258.5 million in cash and no third-party debt, providing flexibility for growth [40] - The company is actively pursuing acquisitions, with $33 million of projected inorganic revenue for 2026, and has already signed several deals [17][74] Q&A Session Summary Question: What is the outlook for revenue growth momentum? - Management indicated that the company operates conservatively and expects to elevate revenue numbers based on strong recurring revenue growth observed in late 2025 [52] Question: Is there any pushback on pricing due to AI? - Management acknowledged some pushback in competitive service areas but emphasized a focus on value-added services rather than commodity pricing [60] Question: What is the pricing contribution for 2026? - The company forecasts high single-digit pricing growth for 2026, with expectations to sustain this level [70] Question: How much of the projected inorganic revenue is from already acquired groups? - Approximately $15 million of the $33 million projected inorganic revenue is already secured from recent acquisitions [74]

Financial Data and Key Metrics Changes - Total revenue for 2025 was $357.5 million, up 0.4% from $356 million in 2024, and adjusted EBITDA was $42 million, up 2.6% from 2024, resulting in an adjusted EBITDA margin of 11.8% [8][10] - Fourth quarter revenue was $93.5 million, down 1.5% from $94.9 million in the same quarter a year ago, with adjusted EBITDA for the quarter at $14.7 million, up 3.3% from the prior year quarter, resulting in an adjusted EBITDA margin of 15.7% [11][13] Business Line Data and Key Metrics Changes - Content & Ad Measurement revenue was $304.3 million, up 1% from 2024, driven by growth in cross-platform and local TV offerings [8] - Cross-platform revenue was $50.3 million, up 24.4% compared to the prior year, driven by higher usage of Proximic and CCR products, along with the successful rollout of CCM [8] - Syndicated Audience revenue was $253.9 million, down 2.6% from 2024, primarily due to declines in national TV and syndicated digital offerings [9] - Research and Insight Solutions revenue was $53.2 million, down 3.1% from 2024, mainly due to lower deliveries of certain custom digital products [9] Market Data and Key Metrics Changes - The local TV business continued to execute at a high level, contributing to double-digit year-over-year growth, while the movies business generated $38.4 million in revenue, up 3.4% from the prior year [9] - The company anticipates continued double-digit growth from cross-platform offerings in 2026, which should offset declines from national TV and syndicated digital products [14] Company Strategy and Development Direction - The company aims to become the industry standard for modern measurement by building a fully integrated flywheel that connects offerings across planning, activation, buying, and measurement [5][6] - The focus is on enhancing cross-platform capabilities and integrating AI measurement to adapt to the evolving media landscape [6][7] - The recapitalization transaction was a pivotal step in transforming the company, allowing for strategic actions to streamline capital structure and enhance financial profile [15] Management's Comments on Operating Environment and Future Outlook - Management highlighted the challenges posed by a fragmented media landscape and the need for modern measurement solutions to navigate complexity [5] - The company expects revenue in the first quarter of 2026 to be roughly flat compared to the first quarter of 2025, while continuing to invest in key areas to drive growth [15] Other Important Information - The company successfully eliminated $18 million in annual dividends and a $47 million special dividend obligation through recapitalization, which positions it better for future investments [3][4] - The company is focused on simplifying its capital structure and strengthening its balance sheet as it moves through 2026 [4] Q&A Session Summary Question: Financial flexibility with structural changes - Management noted that eliminating $18 million in dividends and reducing board size will free up the balance sheet for future investments in growth areas, particularly cross-platform execution [18] Question: Cross-platform utilization and new partnerships - Management reported increased usage of cross-platform audience products and ongoing expansion of partnerships, with positive early adoption of the CCM product [19][20] Question: Local market evolution - Management expressed confidence in the local market's growth, emphasizing the company's unique position in providing local audience measurement and advanced targeting capabilities [22][24]

Financial Data and Key Metrics Changes - The company achieved a net profit swing of $18.9 million, marking a significant turnaround for a microcap public company [4] - Annual revenue was reported at $31.2 million, reflecting a 13% decrease year-over-year due to a strategic pivot towards long-term profitability [4] - Fourth quarter revenue was $6.1 million, down 45% year-over-year, primarily due to strategic client rationalization and delayed bookings [5][12] Business Line Data and Key Metrics Changes - Managed Services revenue, excluding Hoozu, remained relatively flat, finishing the year down only 2% [5] - The company successfully scaled five enterprise accounts beyond the million-dollar threshold, each delivering double or triple-digit growth [6] - Contract bookings declined by $10.3 million or 27% year-over-year, reflecting a reduction in non-core customer activity [11] Market Data and Key Metrics Changes - The company exited international markets and off-boarded lower-margin SMB accounts to focus on high-potential enterprise clients [4] - The strategic shift coincided with government-induced disruptions affecting government and retail accounts [5] Company Strategy and Development Direction - The company is focusing on building deeper vertical expertise and executing key account plans for enterprise accounts [7] - There is an active M&A strategy in place to acquire companies that can enhance capabilities and accelerate growth in the enterprise client portfolio [7][26] - A proprietary technology platform is set to launch, aimed at managing integrated creator campaigns at enterprise scale [8] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's future and its ability to deliver value to stakeholders [9] - The company anticipates a return to year-over-year revenue growth in the second half of 2026 as revenue reflects the current mix of core enterprise engagements [12] Other Important Information - The company achieved a 40% reduction in total operating expenses, leading to a cash operating profit of $0.7 million [6] - As of December 31, 2025, the company had $50.9 million in cash and cash equivalents, indicating improved operating performance [16] Q&A Session Summary Question: Can you give clarity on gross margins going forward? - Management indicated that while specific guidance is not provided, there has been an increase in gross margins relative to previous years, with a focus on growing net revenue [20] Question: Do you expect year-over-year growth in revenues? - Management confirmed that they are aiming for growth, emphasizing the growth potential in the market [21] Question: Can you elaborate on the acquisition strategy and market conditions? - Management stated that they are actively engaged in M&A discussions and see good deal flow, with a focus on acquiring customers rather than technology [22][26] Question: Is the difference in private and public market valuations an issue? - Management acknowledged the valuation difference but stated it is not an issue, highlighting opportunities for investors [24] Question: What is the focus of the acquisition strategy? - The primary focus is on acquiring customers to enhance enterprise-grade client relationships and service offerings [25][26]

Financial Data and Key Metrics Changes - NextNav finished Q4 2025 with approximately $152 million in cash equivalents and short-term investments, indicating a strong liquidity position [12] - The company reported a net loss of roughly $68 million for the quarter, primarily due to non-cash losses of approximately $48 million associated with the change in the fair value of derivative and warrants liability [13] Business Line Data and Key Metrics Changes - NextNav has begun operating the world's first 5G-powered PNT network, marking a significant step towards commercialization [10] - The partnership with Japan's MetCom highlights the international scalability of NextNav's platform and the demand for resilient terrestrial 5G-based 3D PNT solutions [11] Market Data and Key Metrics Changes - The FCC has sent a draft notice of proposed rulemaking (NPRM) focused on PNT technologies to the White House OMB, which is a critical step in the regulatory process [4] - The discussions at industry events emphasized the importance of PNT capabilities as a transformative application for 5G and 6G networks [9] Company Strategy and Development Direction - NextNav aims to provide a terrestrial complement and backup to GPS, addressing vulnerabilities in current systems and enhancing national security [6][10] - The company is focused on advancing its technology and commercialization efforts while maintaining a strong governance structure [11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the path toward an FCC vote on the NPRM, with a clear line of sight to a Report and Order [25] - The company is committed to strengthening U.S. economic and national security through its innovative solutions [25] Other Important Information - NextNav's solution is designed to be future-proof and does not require taxpayer funding, which positions the company favorably in the market [6] - The company has a significant number of warrants expiring in 2026 that could deliver over $200 million in additional capital depending on stock price performance [12] Q&A Session Summary Question: Has the company seen the contents of the NPRM sent to the OMB? - Management confirmed that they have not seen the contents as it is part of the inter-agency review process [15] Question: Will the NPRM likely include a 10 by 5 channel for more precise PNT? - Management indicated that they are testing towards a 10+5 capability as part of their commercialization efforts and are confident in meeting the requirements [16] Question: What learnings have been gained from the MetCom relationship? - Management highlighted the international opportunity presented by the MetCom partnership and its potential to accelerate commercialization in the U.S. [20]

Financial Data and Key Metrics Changes - In 2025, the company reported a loss from operations of $139.3 million, primarily due to payroll, general business expenses, and professional fees related to capital market and asset deployment activities [33] - The loss before income taxes was $110.2 million, which included interest and dividend income of $29.1 million from marketable securities [33] - Cash used in operating activities was $82.2 million, with an adjusted figure of $69.2 million, aligning with the guidance of $65 million-$80 million for 2025 [34] - The company ended 2025 with cash and marketable securities totaling $1.4 billion and raised an additional $1.182 billion in early 2026, completing a $1.5 billion ATM program [36] Business Line Data and Key Metrics Changes - The company transitioned from product development to active project deployment across all business units in 2025, including the groundbreaking of the first Aurora powerhouse at Idaho National Laboratory [3][4] - Significant progress was made in the fuel business unit, with the completion of fast-spectrum plutonium criticality experiments and advancements in fuel recycling initiatives [4][9] - The isotopes business unit is expanding with the construction of the Groves radioisotope test reactor and the Idaho Radiochemistry Laboratory, which is expected to generate revenue in the near term [26][27] Market Data and Key Metrics Changes - The U.S. nuclear policy has shifted towards a more execution-oriented posture, providing a strong tailwind for the nuclear sector, which benefits the company's strategic positioning [4][5] - The demand for clean, reliable baseload power is increasing across various sectors, including data centers and industrial customers, which aligns with the company's power business strategy [6][7] Company Strategy and Development Direction - The company aims to build a vertically integrated nuclear platform encompassing power, fuel, and isotopes, which is designed to unlock multiple complementary value streams over time [5][12] - The strategy includes leveraging federal support mechanisms such as tax credits and loan guarantees to enhance project funding pathways [4][5] - The company is focused on building a more integrated nuclear development model to unlock nuclear energy abundance, with ongoing projects across all three business units [16] Management's Comments on Operating Environment and Future Outlook - Management highlighted the importance of the DOE's Nuclear Lifecycle Innovation Campuses in modernizing the nuclear fuel cycle and improving investment efficiency [15] - The company is optimistic about the regulatory environment, expecting the NRC to issue a new framework for converting DOE-authorized facilities to NRC-licensed facilities, which could expedite future projects [52][56] - Management emphasized the need for flexibility in capital allocation and cash management to support growth opportunities in 2026 and beyond [35] Other Important Information - The company is actively pursuing partnerships for fuel supply and recycling, including a joint venture with Centrus focused on uranium deconversion [25] - The Idaho Radiochemistry Laboratory has obtained its NRC materials license, marking a significant operational milestone [26] Q&A Session Summary Question: Status on commercialization and customer pipeline - Management noted that Meta is a key anchor customer, and discussions are ongoing with other potential customers, including military and industrial sectors [38][39] Question: Breakdown of CapEx guidance for 2026 - Management refrained from providing a detailed breakdown but indicated that significant spending will occur across all business units, particularly in Idaho and Ohio [41][43] Question: Update on COLA timing and NRC licensing - Management clarified that DOE authorization allows for faster project execution and that they are preparing for NRC licensing while leveraging experiences from the DOE pathway [49][50][52]

Financial Data and Key Metrics Changes - Total revenue for the third quarter was $24.6 million, representing a 63% increase compared to the prior year period [9][20] - Gross margin improved to 52.6%, up 9 percentage points year-over-year and 200 basis points sequentially, marking the ninth consecutive quarter of sequential gross margin expansion [9][20] - GAAP net loss was $34.2 million, compared to a GAAP net loss of $21.8 million in the prior year period [24] Business Line Data and Key Metrics Changes - The company accepted over 5,400 prescriptions for the ASSURE System, reflecting a 58% year-over-year increase in prescriptions [9][20] - The conversion rate improved to approximately 46%, up from an adjusted conversion rate of 43% in the prior year period [21] Market Data and Key Metrics Changes - The wearable cardioverter defibrillator (WCD) market is estimated to have grown in the low to mid-teens percentage on a dollar basis in calendar year 2025 [10][11] - The company believes the WCD market will expand into a multi-billion-dollar market in the coming years [10] Company Strategy and Development Direction - The company aims to achieve gross margins of 70% or more over the next few years, supported by strong revenue growth and margin expansion [10][20] - A strategic collaboration with Biobeat Technologies was announced to enhance diagnostic insights for patients, integrating their technology into the product portfolio [13][14] - The company is expanding its sales organization to penetrate existing accounts and attract new prescribers, targeting geographies with high volumes of WCD prescriptions [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's growth trajectory, citing strong performance and the foundation built for durable growth [18][19] - The management highlighted the importance of clinical data from the ACE-PAS study in driving clinician engagement and market expansion [12][48] Other Important Information - The company became an approved Florida managed Medicaid provider, which is expected to enhance market share in Florida [16][60] - The monthly Medicare reimbursement rate for WCDs increased by 2% to $3,589 as of January 1 [17] Q&A Session Summary Question: Thoughts on early 2027 model and $133 million consensus - Management is confident in delivering top-tier med tech growth in 2027 and will provide more details at the next earnings call [29] Question: Acceleration in WCD market growth - Management noted that increased commercial team size and clinical results are driving market growth, with expectations for continued acceleration [31][34] Question: Prescription growth sources - Approximately 70%-75% of prescription growth is attributed to market share shift, with 25% from new prescribers [38] Question: Competitive environment and pricing - Management indicated no pricing headwinds and emphasized ongoing competition without significant obstacles from competitors [42] Question: Florida Medicaid provider status impact - The approval is expected to enhance growth in Florida, although it will take time to see full benefits [60] Question: CapEx spending as a leading indicator - Management indicated that CapEx spending is aligned with the growth strategy, with expectations for continued investment in inventory and service levels [83] Question: Cash burn outlook - Management expects cash burn to remain in the mid-$20 million range for the next year, excluding specific investments [85]

Financial Data and Key Metrics Changes - ClearPoint Neuro reported total revenues of $37 million for the year ended December 31, 2025, an increase from $31.4 million in 2024, with $1.2 million attributed to the acquisition of IRRAS Holdings, Inc. [10] - Gross margin for 2025 was 61%, consistent with 2024 [12] - Net cash flows used in operating activities increased to $23.9 million in 2025, up from $8.9 million in 2024 [19] Business Line Data and Key Metrics Changes - Biologics and Drug Delivery revenue increased by 10% to $19 million in 2025, up from $17.3 million in 2024, driven by increased product sales [11] - Neurosurgery Navigation revenue grew to $14.8 million in 2025, including $1.2 million from IRRAflow, primarily due to an expanded installed base and the market release of new products [11] - Capital equipment and software revenue was $3.1 million for 2025, showing a slight decrease compared to previous periods [12] Market Data and Key Metrics Changes - The company expects revenues for 2026 to be in the range of $52 million to $56 million, reflecting factors such as FDA communications regarding rare diseases and integration efforts from the IRRAS acquisition [8] - The company is targeting a $1 billion market opportunity across four product segments, expecting double-digit growth in each segment for 2026 [6][21] Company Strategy and Development Direction - ClearPoint Neuro is focused on developing a complete neuro ecosystem for minimally invasive treatments, including cell and gene therapies [4] - The company has entered two phases of growth strategy: "Fast Forward" to penetrate existing markets and "Essential Everywhere" to build a new market for commercial cell and gene therapy delivery [6][7] - The company aims to achieve 20% market share in its existing $1 billion market and generate $200 million in annual revenue [34] Management's Comments on Operating Environment and Future Outlook - Management highlighted the strong financial performance in Q4 2025 and expressed optimism about the future, emphasizing the importance of their biopharma partnerships and clinical trials [21][26] - The management acknowledged challenges related to FDA communications on rare diseases but remains focused on larger patient populations and established markets [40][42] Other Important Information - The company has invested over $100 million in the past five years to build a strong foundation, including a robust pipeline of development programs and an expanded manufacturing footprint [5] - ClearPoint Neuro has over 60 active biopharma partners and is involved in more than 25 active clinical trials [5][24] Q&A Session Summary Question: Clarification on 2026 guidance and organic growth - Management discussed the impact of FDA communications on rare diseases and integration priorities from the IRRAS acquisition on revenue guidance [39][40] - The company expects balanced growth between organic and inorganic sources, with all segments projected to grow in double digits [45][46] Question: Pathway to $200 million revenue - Management indicated a growth rate of 15%-20% could be expected as the company integrates IRRAS and expands its market share [49][50] Question: Updates on expedited review partners - Management confirmed more than 10 partners are in expedited review pathways, with significant indications including Parkinson's disease and drug-resistant epilepsy [60] Question: Timeline for expansion into neuro-oncology - Management emphasized the strength of their commercial team and the importance of upcoming clinical data to support expansion into neuro-oncology [62]